Literature DB >> 191243

Enhancement of [3H-methyl]thymidine incorporation and replication of rat chondrocytes grown in tissue culture by plasma, tissue extracts and vasopressin.

R P Miller, F Husain, M Svensson, S Lohin.   

Abstract

A pituitary mitogenic peptide, which stimulates cellular replication of a variety of cells maintained in tissue culture, has been identified by other investigators. To study this mitogenic substance, we developed an assay to measure mitogenic substances utilizing fetal rat chondrocytes grown in monolayer culture. Mitogenic activity of added test substances was determined by [3H-methyl]thymidine incorporation into trichloroacetic acid insoluble cell products and increase in total cell number after 24 h exposure. Extracts of whole pituitary glands were more potent in stimulating these cellular indices than either those of liver or muscle, confirming that the chondrocytes are sensitive to the described mitogen. Identically prepared extracts of either anterior or posterior pituitary lobes were mitogenic indicating the presence of two or more mitogenic substances in crude pituitary extracts. Synthetic lysine vasopressin and a beef pitressin concentrate stimulated thymidine incorporation into chondrocytes in the absence of calf serum and this effect was additive to that of calf serum, suggesting that the mitogenic substance of posterior pituitary extracts was vasopressin. The maximum effective dose of vasopressin leading to an increase in either thymidine incorporation or total cell number was between 100 to 500 pg/ml, and as little as 50 pg/ml of hormone elicited an increase in total cell number. The mitogenic effect of both vasopressin and calf serum on chondrocytes was partially inhibited by 1 X 10(-4)M N, O'dibutryl cyclic adenosine 3',5' monophosphate suggesting that cell division of chrondrocytes may be under tonic control by the andenylyl cyclase system. We conclude that vasopressin is a potent mitogen for chondrocytes maintained in tissue culture and its presence must be rigorously excluded in evaluating mitogenic activity of pituitary or serum concentrates.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191243     DOI: 10.1210/endo-100-5-1365

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function.

Authors:  J Howl; T Ismail; A J Strain; C J Kirk; D Anderson; M Wheatley
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Vasopressin accelerates protein synthesis in neonatal rat cardiomyocytes.

Authors:  Y Xu; R L Hopfner; J R McNeill; V Gopalakrishnan
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  Vasopressin stimulation of mouse 3T3 cell growth.

Authors:  E Rozengurt; A Legg; P Pettican
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 4.  Neuropeptides as growth and differentiation factors in general and VIP in particular.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

Review 5.  Neurohypophyseal peptides as regulators of growth and development. A review.

Authors:  D A Carter; C K Fai; D Murphy
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

6.  Regulated expression of proenkephalin A during ontogenic development of mesenchymal derivative tissues.

Authors:  R D Polakiewicz; H Rosen
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Characteristics of human chondrocyte cultures in completely defined medium.

Authors:  E R Schwartz; G Sugumaran
Journal:  In Vitro       Date:  1982-03

8.  Receptor for bombesin with associated tyrosine kinase activity.

Authors:  D M Cirillo; G Gaudino; L Naldini; P M Comoglio
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  AVPR1A distribution in the whole C57BL/6J mouse neonate.

Authors:  Katherine R Day; Alexis Coleman; Maria A Greenwood; Elizabeth A D Hammock
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.